Michael Mina, MD, PhD - 2021 World Medical Innovation Forum
Mina, Michael
This speaker appears at this event:

This speaker’s events are being finalized

Michael Mina, MD, PhD

    • Associate Medical Director, Molecular Virology, BH

    • Assistant Professor, Epidemiology, Immunology and Infectious Diseases, Harvard Chan School

Michael Mina, MD, PhD is an Assistant Professor in the Department of Epidemiology and the Department of Immunology & Infectious Diseases at the Harvard School of Public Health and a clinical pathologist at Brigham and Women’s Hospital / Harvard Medical School. After earning his AB at Dartmouth College in engineering and public health, he completed his MD and PhD degrees in the NIH Medical Scientist Training Program at Emory University and subsequently completed post-doctoral work at Princeton University and Harvard Medical School. He completed his medical residency in clinical pathology at Brigham and Women’s Hospital and Harvard Medical School.

Dr. Mina’s research focuses on the development of novel high-throughput technologies to advance infectious disease diagnostics and epidemiological surveillance, and understand interactions between pathogen exposures and immunity. His work has uncovered prolonged effects of measles infections to delete previously acquired immunity, and has linked measles vaccines to benefits towards reducing mortality by as much as 50% globally. More broadly, a major interest of his lab is the development of molecular and mathematical tools to understand the landscape of infectious diseases and development of immunity, across ages and across the world, through the development and coupling of novel high throughput serological tools with new statistical methods. Recently, for obvious reasons, his research has taken a turn towards understanding the epidemiology and immunology relating to the novel coronavirus.

Michael’s research has been reported nationally and internationally in most major media outlets and Michael has been the recipient of numerous awards for his research and public health work, including being named by The Economist as one of eight “Global Progress Makers”, his research was awarded the top scientific research award for junior investigators from the US Academy of Clinical and Laboratory Physicians and Scientists, and most recently Michael is the recipient of a NIH Director’s Early Independence Award.